These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 8364489)

  • 1. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of pH on the generation of turbidity and elasticity associated with fibrinogen-fibrin conversion by thrombin are remarkably influenced by sialic acid in fibrinogen.
    Okude M; Yamanaka A; Akihama S
    Biol Pharm Bull; 1995 Feb; 18(2):203-7. PubMed ID: 7742784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and metabolic properties of human asialofibrinogen.
    Martinez J; Palascak J; Peters C
    J Lab Clin Med; 1977 Feb; 89(2):367-77. PubMed ID: 833473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'.
    Okumura N; Terasawa F; Haneishi A; Fujihara N; Hirota-Kawadobora M; Yamauchi K; Ota H; Lord ST
    J Thromb Haemost; 2007 Dec; 5(12):2352-9. PubMed ID: 17922804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen sialic acid residues are low affinity calcium-binding sites that influence fibrin assembly.
    Dang CV; Shin CK; Bell WR; Nagaswami C; Weisel JW
    J Biol Chem; 1989 Sep; 264(25):15104-8. PubMed ID: 2549051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of divalent cations on the conversion of fibrinogen to fibrin and fibrin polymerization.
    Kanaide H; Uranishi T; Nakamura M
    Am J Hematol; 1982 Nov; 13(3):229-37. PubMed ID: 7180836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Participation of sialic acid residue in the fibrinogen-fibrin conversion by thrombin].
    Akihama S; Matsuda Y; Fukase T; Yamanaka A; Okude M
    Yakugaku Zasshi; 1995 Jul; 115(7):537-42. PubMed ID: 7562401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
    Ruf W; Bender A; Lane DA; Preissner KT; Selmayr E; Müller-Berghaus G
    Biochim Biophys Acta; 1988 May; 965(2-3):169-75. PubMed ID: 3365451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of the gamma-chain Asn308 disturbs the D:D interface affecting fibrin polymerization, fibrinopeptide B release, and FXIIIa-catalyzed cross-linking.
    Okumura N; Gorkun OV; Terasawa F; Lord ST
    Blood; 2004 Jun; 103(11):4157-63. PubMed ID: 14764520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ioxaglate--an ionic low osmolar contrast medium--on fibrin polymerization in vitro.
    Brass O; Belleville J; Sabattier V; Corot C
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):689-97. PubMed ID: 8292718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-step fibrinogen--fibrin transition in blood coagulation.
    Blombäck B; Hessel B; Hogg D; Therkildsen L
    Nature; 1978 Oct; 275(5680):501-5. PubMed ID: 692730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of clotting factors from Agkistrodon acutus venom.
    Komori Y; Nikai T; Sakairi Y; Sugihara H
    Int J Biochem; 1988; 20(4):387-92. PubMed ID: 2896611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for four different polymerization sites involved in human fibrin formation.
    Olexa SA; Budzynski AZ
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1374-8. PubMed ID: 6929491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin.
    Siebenlist KR; DiOrio JP; Budzynski AZ; Mosesson MW
    J Biol Chem; 1990 Oct; 265(30):18650-5. PubMed ID: 2211727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.